Cannasouth Ltd banner

Cannasouth Ltd
NZX:CBD

Watchlist Manager
Cannasouth Ltd Logo
Cannasouth Ltd
NZX:CBD
Watchlist
Price: 0.098 NZD Market Closed
Market Cap: NZ$32.4m

Cannasouth Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cannasouth Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Cannasouth Ltd
NZX:CBD
Net Income (Common)
-NZ$8.8m
CAGR 3-Years
-36%
CAGR 5-Years
-105%
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Net Income (Common)
NZ$838k
CAGR 3-Years
N/A
CAGR 5-Years
-12%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Net Income (Common)
NZ$17.4m
CAGR 3-Years
1%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Net Income (Common)
-NZ$3.5m
CAGR 3-Years
26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Cannasouth Ltd
Glance View

Market Cap
32.4m NZD
Industry
Pharmaceuticals

Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.

CBD Intrinsic Value
Not Available

See Also

What is Cannasouth Ltd's Net Income (Common)?
Net Income (Common)
-8.8m NZD

Based on the financial report for Dec 31, 2023, Cannasouth Ltd's Net Income (Common) amounts to -8.8m NZD.

What is Cannasouth Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-105%

Over the last year, the Net Income (Common) growth was -7%. The average annual Net Income (Common) growth rates for Cannasouth Ltd have been -36% over the past three years , -105% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett